Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

Torrent Pharma's acquisition of JB Chemicals & Pharmaceuticals propels it to become India's fifth-largest pharmaceutical ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

The deal is expected to strengthen Torrent's market share in the Indian pharmaceutical market and diversify its platform into ...

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

Torrent Pharmaceuticals acquires JB Chemicals to expand into new therapies and international markets, aiming for long-term ...

Torrent Pharmaceuticals has signed a definitive agreement to acquire a controlling stake in JB Chemicals and Pharmaceuticals ...

Shares of Torrent Pharmaceuticals surged nearly 4% in opening trade on Monday following the announcement to acquire a ...

JB Chemicals already has an established domestic business, with 58% of its overall sales coming from the domestic market.

Torrent Pharmaceuticals acquires controlling stake in JB Chemicals and Pharmaceuticals from KKR, followed by merger for ...

Torrent expects to reach a peak leverage of 2.8x by FY27 in a worst-case scenario, but anticipates reducing it to below 0.5x within two years post-merger.

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR, and plans to merge ...